instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
"Costs and the cost-effectiveness of this strategy are not discussed. Any discussion of a preventive strategy should include comments on cost. Avandia and metformin, at the doses used in the study, cost about $195 a month, according to drugstore.com. We get absolute benefits, relative benefits, and the all-important number needed to treat (NNT). Very nice. While harms weren’t quantified, the story provided a good amount of detail, context, and caveat about the safety of this regimen. We get many important details about the study: the number of patients, the enrollment criteria, randomization, placebo control, half doses, and the length of follow-up. It also describes some limitations of the study, such as its inability to detect rare adverse events due to its size. It’s an important caveat, particularly with a cardiovascular cloud hanging over rosiglitazone. The author also points to the editorial’s observation that the approach didn’t affect the problems in the pancreas that underly diabetes and which must be addressed by such a strategy. The author is very specific about the thresholds for the patient population, and who was considered at high risk to progress to diabetes. We note that it was judiciously limited in its use of the term ""prevention."" Props to the author for citing the editorial written by two independent experts and published in the same issue of the Lancet. This article selects several of their many cogent comments. Ideally, another independent source outside the publication would’ve been consulted, too. The story describes how GSK has a dog in this fight, funding the study and manufacturing Avandia. The story also provides the institutional affiliations of Zinman and the two editorialists. While it’s probably covered in the GSK funding source, we’ll point out that several investigators had other financial ties to GSK, too. The article talks about the effectiveness of lifestyle changes and the challenge of implementing them. It also reviews the barriers to using full-dose rosi because of adverse events. It’s clear Avandia and metformin are currently available. We’re told of similar prior studies and the novelty of attempting a low-dose regimen to block progression. We don’t see evidence that the article relied on any news releases."
answer:
Low-dose combination of Avandia and metformin decreases progression to diabetes by two-thirds with few side effects


question:
That’s the advice to care givers from a consortium of nutritional researchers following a two-year survey of what U.S. cancer patients prefer to eat and drink. The study released on Tuesday by the Cancer Nutrition Consortium aims to improve the lives of cancer patients by helping them get the meals they want while combating the weight loss and fatigue that often comes with aggressive treatment. Researchers surveyed 1,203 patients at seven of the world’s leading cancer centers, including Dana-Farber and the Mayo Clinic, and found 40 percent developed more sensitive palates after starting treatments like chemotherapy and radiation. Some 52 percent of the surveyed patients said they were avoiding greasy or fried foods, 44 percent said they were avoiding spicy foods, and nearly a third said they were avoiding acidic foods like grapefruit. Most patients cited intolerance, while less than half said they were acting on the advice of doctors. Some 69 percent of patients said they preferred fruits and vegetables, around 60 percent favored soups and poultry, and more than half said they liked pasta and fish, according to the research. “Typically the patients ran for the healthier foods. But there were exceptions, and it is important to keep in mind that it is not one size fits all,” said Kathy McManus, director of nutrition at Dana-Farber. The study also showed most patients staying away from beverages like beer, wine and soda, while gravitating toward healthier options like water and fruit juice. “Many of our patients suffer from problems getting adequate nutrition through treatment, and some of them are unsure about what they should be eating,” said Terry Langbaum, chief operating officer for Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which also participated in the study. “This research study involved the patients and truly helped us to better understand preferences,” he said. The study was underwritten by Jeremy Jacobs, chairman and CEO of global food and hospitality service provider Delaware North Companies, and conducted by marketing firm WHP Research. The research recommends care givers develop recipes, prepared foods and menus that are tailored to the preferences of cancer patients, but is not intended to advance Delaware North’s business, WHP President Wendy Price said. The Cancer Nutrition Consortium said it was launching a website that includes recipes designed by chefs and tailored to the findings of the survey. The bottom line for hospital kitchens putting together their menus in the oncology ward: “Limit greasy and fried food offerings since about one-half of patients are avoiding these types of foods,” according to the study.
answer:
Broccoli not burgers: Cancer patients favor healthier foods.


question:
A coalition sent letters this month to universities, asking campuses to join Indiana University and Purdue University in the vaccination requirement, The Wisconsin State Journal reported. The shots are typically covered by insurance and cost about $200. The Centers for Disease Control and Prevention recommends that children age 11 or 12 should be vaccinated against the four common strains of meningococcal bacteria — A, C, W and Y — and get a booster shot at 16. People age 16 to 18 should consider getting the newer vaccine for strain B, the CDC said. UW-Madison won’t be requiring the shot until the CDC upgrades its guidelines, said Dr. William Kinsey, medical director. “We are not convinced that the benefit lasts long enough that we know it’s worth vaccinating everyone for it,” he said. “Each student should have a discussion about the risks and benefits of getting that vaccine with their primary care provider.” About 21,000 UW-Madison students, or 70 percent of undergraduates, received the first dose of meningitis B vaccine in 2016 after three students developed serious cases. At least 9,000 students decided to get the second dose, Kinsey said. College students are at an increased rise of acquiring bacterial meningitis because they tend to share food and drink, health officials said. Gail Bailey’s son, Eddy Bailey, was 20 when he died from the rare but potentially fatal disease in 2002 while he was a student at UW-Madison. Immunizations are worth it even if it saves just one life, she said. “If we can do something about it, why not do something about it?” she said. ___ Information from: Wisconsin State Journal, http://www.madison.com/wsj
answer:

Groups ask UW-Madison to require meningitis B vaccine.